CLOV

Clover Health Investments, Corp.

0.95 USD

Last updated Dec 8, 22:47 UTC

Yesterday HIGH

$0.95

Yesterday LOW

$0.92

52w HIGH

$1.63

52w LOW

$0.71

EPS

-0.09

PE

-10.60

Next Earnings

Feb 27, 2024

Overview News Government Trades

Clover Health Investments, Corp. stock is up 6.02% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November.

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company also focuses on non-insurance businesses.

Stock Exchange

NYSE

Sector

Finance, Insurance, And Real Estate

Industry

Insurance

Headquarters

Franklin, United States Of America

Website

cloverhealth.com

Benzinga Newsdesk

Fri Jun 30, 2023

Center for Medicare & Medicaid Services Releases Revised Guidance For Historic Medicare Drug Price Negotiation Program; By September 1, CMS Will Publish The List Of The First 10 Drugs Covered Under Part D Selected For Initial Price Applicability Year 2026

https://www.cms.gov/newsroom/press-releases/cms-releases-revised-guidance-historic-medicare-drug-price-negotiation-program
Benzinga Newsdesk

Thu Jun 22, 2023

Clover Health Investments Reaches Agreement In Principle To Resolve Seven Derivative Lawsuits Pending In Delaware, New York, And Tennessee Courts; Terms Not Disclosed

On June 21, 2023, the plaintiffs in the derivative lawsuits, on the one hand, and the Company, on the other hand, entered into a memorandum of understanding providing for the settlement of the derivative actions.
Benzinga Newsdesk

Thu Jun 22, 2023

Clover Health Announces Agreement To Settle Derivative Litigation, Resolving All Remaining Civil Litigation Relating To Its de-SPAC Transaction
Happy Mohamed

Wed Jun 21, 2023

Pharmaceutical Research And Manufacturers Of America Says Suing U.S. Government To Block Enforcement Of Program That Gives Medicare Too Much Power To Set Drug Prices

- Reuters
Lisa Levin

Mon Jun 5, 2023

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Benzinga Newsdesk

Thu Jun 1, 2023

Centers For Medicare & Medicaid Services Announces Plan To Ensure Availability Of New Alzheimer's Drugs; Outlines How People With Medicare Can Get These Alzheimer's Drugs If FDA Grants Traditional Approval

-Reuters
Adam Eckert

Wed May 10, 2023

What's Going On With Clover Health Stock Wednesday?

Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower Wednesday on the heels of the company's first-quarter report.
Benzinga Insights

Tue May 9, 2023

Recap: Clover Health Investments Q1 Earnings
Benzinga Newsdesk

Tue May 9, 2023

Clover Health Sees FY23 Insurance Revenue $1.18B-$1.23B, Adj. EBITDA $(175M)-$(125M)
Benzinga Newsdesk

Tue May 9, 2023

Clover Health Investments Q1 Sales $527.77M Beat $498.74M Estimate

Clover Health Investments (NASDAQ:CLOV) reported quarterly sales of $527.77 million which beat the analyst consensus estimate of $498.74 million by 5.82 percent. This is a 39.64 percent decrease over sales of $874.38

VRTX $350.22 USD

HOOD $11.73 USD

BMEA BMEA $16.85 USD

MDGL $209.14 USD

AFRM $42.07 USD

CRSP $64.52 USD

LULU $489.86 USD

PARA $16.84 USD

BRLI BRLI $13.10 USD

ORCL $113.63 USD